GSK-Backed Ouro Launches With $120m For T-Cell Engagers In Autoimmune Diseases

Lead TCE, Licensed From Keymed, Targets BCMA

 
• By Mandy Jackson
  
Monograph invested in Ouro predecessor HI-Bio (Shutterstock)

More from Financing

More from Leadership